Cardiac Tumors: JACC CardioOncology State-of-the-Art Review

S Tyebally, D Chen, S Bhattacharyya, A Mughrabi… - Cardio Oncology, 2020 - jacc.org
Cardiac masses are rare, but remain an important component of cardio-oncology practice.
These include benign tumors, malignant tumors (primary and secondary) and tumor-like …

Circular RNA ZNF609/CKAP5 mRNA interaction regulates microtubule dynamics and tumorigenicity

F Rossi, M Beltran, M Damizia, C Grelloni, A Colantoni… - Molecular cell, 2022 - cell.com
Circular RNAs (circRNAs) are widely expressed in eukaryotes and are regulated in many
biological processes. Although several studies indicate their activity as microRNA (miRNA) …

Non-squamous laryngeal cancer

SD MacNeil - Otolaryngologic Clinics of North America, 2023 - oto.theclinics.com
Non-squamous cell carcinoma (SCC) of the larynx represents approximately 5% of
laryngeal malignancies. 1 These malignancies originate from minor salivary glands, bone …

18F-FDG PET-CT in paediatric oncology: established and emerging applications

G Chambers, R Frood, C Patel… - The British Journal of …, 2019 - academic.oup.com
Accurate staging and response assessment is vital in the management of childhood
malignancies. Fluorine-18 fluorodeoxyglucose positron emission tomography/CT (FDG PET …

CT-based radiomics to differentiate pelvic rhabdomyosarcoma from yolk sac tumors in children

X Chen, Y Huang, L He, T Zhang, L Zhang… - Frontiers in …, 2020 - frontiersin.org
Background The purpose of this study was to investigate the role of CT radiomics features
combined with a support vector machine (SVM) model in potentially differentiating pelvic …

Systemic therapy in non-conventional cancers of the larynx

E Tan, MD Mody, NF Saba - Oral oncology, 2018 - Elsevier
Laryngeal cancer (LC) remains a challenging disease to treat. The majority of LCs
diagnosed worldwide are squamous cell carcinomas (SCC), and current treatment …

Non-inferior efficacy of non-surgical treatment to surgical treatment in patients with nonmetastatic head and neck rhabdomyosarcoma: a SEER-based study

W Liang, L Li, M Wang, Y Liu, Y Qiu, B Zhang… - Clinical and …, 2023 - Springer
Purpose Head and neck rhabdomyosarcoma (HNRMS) is a rare but aggressive malignant
neoplasm. Given the young patient age and critical anatomy of the head and neck …

[PDF][PDF] The natural origins of cytostatic compounds used in rhabdomyosarcoma therapy

D Lewandowski, A Szewczyk, J Radzka… - Adv. Clin. Exp …, 2023 - researchgate.net
Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and
represents a highgrade neoplasm of skeletal myoblast-like cells. About 40% of all registered …

CD56–chimeric antigen receptor T-cell therapy for refractory/recurrent rhabdomyosarcoma: A 3.5-year follow-up case report

C Jiang, W Zhao, M Qin, M Jin, L Chang, X Ma - Medicine, 2019 - journals.lww.com
Interventions: After repeated recurrence, the patient was treated with chimeric antigen
receptor T (CAR-T) cells, which had a safety mechanism and specifically bound the CD56 …

Rhabdomyosarcoma of the oral cavity in children aged 0–2 years: A scoping review

MM Nunes, AAS da Costa, TS Tavares… - Journal of Oral …, 2023 - Wiley Online Library
Background The aim of this study was to collect, synthesize, and analyze the clinic‐
demographic data of rhabdomyosarcoma affecting the oral cavity of young children …